Back to mobile site

Walgreens (WAG) Comps Rose 7.9% in Sept.

October 3, 2014 8:01 AM EDT

Walgreens (NYSE: WAG) had September sales of $6.48 billion, an increase of 9.4 percent from $5.92 billion for the same month in fiscal 2014.

Total front-end sales increased 2.2 percent in September compared with the same month in fiscal 2014, while comparable store front-end sales increased 1.7 percent. Customer traffic in comparable stores decreased 2.7 percent while basket size increased 4.4 percent.

Prescriptions filled at comparable stores increased by 6.6 percent in September and increased 3.9 percent on a calendar day-shift adjusted basis. September 2014 had one additional Tuesday and one fewer Sunday compared with September 2013. These calendar shifts positively impacted prescriptions filled at comparable stores by 2.7 percentage points.

September pharmacy sales increased by 14.2 percent. Comparable store pharmacy sales increased 11.3 percent and increased by a calendar day-shift adjusted 8.6 percent. Calendar day shifts positively impacted pharmacy sales in comparable stores by 2.7 percentage points. Calendar day-shift adjusted comparable store pharmacy sales were negatively impacted by 1.9 percentage points due to generic drug introductions in the last 12 months. Pharmacy sales accounted for 67.8 percent of total sales for the month.

Flu shots administered at pharmacies and clinics season to date were more than 2.1 million versus approximately 1.9 million last year.

Sales in comparable stores increased by 7.9 percent in September. Calendar day shifts positively impacted total comparable sales by 1.8 percentage points. Generic drug introductions in the last 12 months negatively impacted total comparable sales by 1.3 percentage points.

Calendar 2014 year-to-date sales for the first nine months were $57.40 billion, an increase of 6.1 percent from $54.10 billion in 2013.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Retail Sales